Maintenance Notice (10:30 PM January 4 - 8:00 AM January 5, 2025 UTC): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.197 | Notice of Discontinuing the Use of Password-Protected Compressed Files | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 85118-33-8 | Product Number: G0405
Gaboxadol Hydrochloride
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
- 4,5,6,7-Tetrahydroisoxazolo[5,4-c]pyridin-3-ol Hydrochloride
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 25MG |
$89.00
|
32 | 18 | Contact Us |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
| Product Number | G0405 |
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__6H__8N__2O__2·HCl = 176.60 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| Packaging and Container | 25MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 85118-33-8 |
| Related CAS RN | 64603-91-4 |
| Reaxys Registry Number | 6534899 |
| PubChem Substance ID | 253659629 |
| Merck Index (14) | 4321 |
| MDL Number | MFCD00055180 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Elemental analysis(Nitrogen) | 15.40 to 16.30 % |
Properties (reference)
| Melting Point | 236 °C |
GHS
Related Laws:
| RTECS# | NY3398000 |
Transport Information:
| H.S.code* | 2934.99-000 |
Application
Gaboxadol Hydrochloride: A γ-Aminobutyric Acid Subtype A (GABAA) Receptor Agonist
Gaboxadol hydrochloride, also known as THIP, is a direct-acting γ-aminobutyric acid subtype A (GABAA) receptor agonist. GABAA receptor is widely considered to be an important target for most clinically effective sedative-hypnotic compounds. However, the clinical development program for gaboxadol was discontinued in 2007. (The product is for research purpose only.)
References
- Pharmacological characterization of a novel cell line expressing human α4β3δ GABAA receptors
- GABAA receptor α4 subunits mediate extrasynaptic inhibition in thalamus and dentate gyrus and the action of gaboxadol
- An extrasynaptic GABAA receptor mediates tonic inhibition in thalamic VB neurons
- Gaboxadol - a new awakening in sleep(a review)
- GABAA agonists and partial agonists: THIP (Gaboxadol) as a non-opioid analgesic and a novel type of hypnotic(a review)
- Development and validation of a selective and sensitive bioanalytical procedure for the quantitative determination of gaboxadol in human plasma employing mixed mode solid phase extraction and hydrophilic interaction liquid chromatography with tandem mass spectroscopic detection
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.